Breast cancer cells with doubled genomes may dodge immunotherapy by turning off key immune signals

MedicalXpress | mai 13, 2026

An epigenetic mechanism by which tumors manage to hide from the body's immune defenses has just been described by an international scientific team led by the University of Liège and the Dana-Farber Cancer Institute. These findings open up avenues for new therapeutic strategies combining epigenetics and immunotherapy. The paper is published in the journal Cancer Cell.